This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


ReNeuron Group plc

Drug Names(s): ReN003 stem cell therapy, human retinal precursor cells (hRPCs)

Description: ReN003 cell therapy consists of human retinal precursor cells (hRPCs) that have been generated using ReNeuron's proprietary cell expansion and cell selection technologies.

ReN003 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug